Training in vaccinology – viral vaccine process development
|Date & Time||September 10-11 2019|
|Address||Merck/M Lab, Molsheim, France|
|Location||VFI in collaboration with Merck/M Lab, Molsheim, France|
Process development and scale-up of viral vaccines
Using a combination of theory and hands-on instruction, participants will learn the following:
- Key best practices and methods for vaccine process development from upstream to downstream focusing on a viral vaccine platform.
- Best practices of cell culturing in single use bioreactors for both adherent and suspension cells.
- Optimization of filtration and purification technologies
- Adjuvant filtration
- How to integrate vaccine processes in a single use environment
Understand challenges and integrate key considerations for optimal viral vaccine process development and transition to manufacturing Learn how to implement a single use technology based process for viral vaccines
INTERESTED IN THIS COURSE?
The course is offered free of charge. Participants will be selected by a course selection panel.
For more information about the training modules offered by TRANSVAC, the eligibility criteria and the application process, please visit here.
TRANSVAC2 TRAINING MODULES
The training module is part of a series of 14 training modules dedicated to vaccinology set up by the TRANSVAC2 consortium at leading European centres. The modules can be combined to create customised international courses on vaccine R&D. Two rounds of customised training courses are planned. Participants can select topics as needed in their field of vaccine development, and the timelines of the various modules will be harmonised in a way that allows a logical continuation from one topic to the other.